BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240207T170000
DTEND;TZID=UTC:20240207T200000
DTSTAMP:20240131T205438Z
CREATED:20240131T205438Z
LAST-MODIFIED:20240131T205438Z
UID:5187-1707325200-1707336000@thebiocalendar.com
SUMMARY:Targeting Brain Delivery of Biotherapeutics for CNS Diseases
DESCRIPTION:Rapid progress in identifying human genetic risk associated with neurodegenerative disease has revealed numerous genes involved in neurodegeneration. Degenogenes are genes that when mutated cause\, or are major risk factors for\, neurodegenerative disease. These degenogenes highlight important disease pathways for therapeutic discovery\, including lysosomal function\, glial biology and cellular homeostasis. \nAdvances in the genetics\, pathology and cell biology underlying chronic neurodegenerative disease have identified pathways that trigger neurodegeneration and contribute to disease onset and progression. \nNovel delivery approaches being developed at Denali are being used to deliver both small and large molecules across the blood brain barrier to address the high unmet need in Parkinson’s Disease\, Frontotemporal Dementia-Granulin\, ALS\, Multiple Sclerosis\, and other diseases. \nJoe Lewcock will speak about developing therapeutics involved in lysosomal function\, glial biology\, cellular homeostatis for neurodegenerative diseases.
URL:https://thebiocalendar.com/event/targeting-brain-delivery-of-biotherapeutics-for-cns-diseases/
LOCATION:Brisbane\, CA 94005\, Brisbane\, CA\, 94005\, United States
END:VEVENT
END:VCALENDAR